Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $267.3 million.

  • Dexcom's Net Income towards Common Stockholders rose 7620.3% to $267.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $836.3 million, marking a year-over-year increase of 4514.06%. This contributed to the annual value of $836.3 million for FY2025, which is 4514.06% up from last year.
  • As of Q4 2025, Dexcom's Net Income towards Common Stockholders stood at $267.3 million, which was up 7620.3% from $283.8 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Net Income towards Common Stockholders ranged from a high of $283.8 million in Q3 2025 and a low of -$5.3 million during Q4 2021
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $110.6 million (2023), whereas its average is $125.6 million.
  • As far as peak fluctuations go, Dexcom's Net Income towards Common Stockholders crashed by 10128.86% in 2021, and later soared by 183207.55% in 2022.
  • Over the past 5 years, Dexcom's Net Income towards Common Stockholders (Quarter) stood at -$5.3 million in 2021, then skyrocketed by 1832.08% to $91.8 million in 2022, then skyrocketed by 179.19% to $256.3 million in 2023, then tumbled by 40.81% to $151.7 million in 2024, then soared by 76.2% to $267.3 million in 2025.
  • Its Net Income towards Common Stockholders stands at $267.3 million for Q4 2025, versus $283.8 million for Q3 2025 and $179.8 million for Q2 2025.